|
The Challenges of Emerging Markets
|
|
|
| By
Bikash Chatterjee
|
|
|
|
The difficulties of doing business in China are offset by its adoption of more stringent GMP standards.
|
|
|
|
Preparing For the New China
|
|
|
| By
Jon Zifferblatt
|
|
|
|
China's healthcare reforms generate uncertainty for its domestic pharmaceutical market.
|
|
|
|
What the 2011 Census of India Reveals for Pharma
|
|
|
| By
Mangeshi Sai
|
|
|
|
The census reveals the state of the population of India's health and the potential for growth in the healthcare market.
|
|
|
|
Trends and Challenges in Biologics Outsourcing: A Q&A with Stephen Taylor
|
|
|
|
Stephen Taylor PhD, vice-president and commercial director at Fujifilm Diosynth Biotechnologies, addresses some of the challenges facing biologics outsourcing.
|
|
|
|
Assessing the Risk of Leachables from Single-Use Systems
|
|
|
| By
Paul F. Killian
|
|
|
|
This article is the second in a two-part series on extractables and leachables.
|
|
|
|
A Risk-Based Approach to Transferring a Mature Biopharmaceutical Process
|
|
|
| By
Jean Harms
,
Purav Dave
|
|
|
|
Strategies for transfer of the manufacturing process.
|
|
|
|
PQRI Case Study: Facility Biocontainment and Inactivation
|
|
|
| By
Steve Reich
,
Kristin Murray
,
Ted Frank
,
Stephen Brooks
,
Ed Sanchez
,
Brian Hasselbalch
,
Kwame Obeng
,
Richard Creekmore
|
|
|
|
A Risk-Management Case Study.
|
|
|
|
A 25-Year Retrospective on Mammalian Cell Culture
|
|
|
|
This month, we revisit "Industrial-Scale Mammalian Cell Culture, Part I: Bioreactor Design Considerations."
|
|
|
